Skip to content

ORBIMED ADVISORS LLC: OCUL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on OCUL, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 220,000 OCUL shares at 2026-09-30 per its 13F-HR filed 2026-11-16.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 220,000 shares
    Change vs previous 13F 0 shares

    0.03% of the 13F portfolio, value $1,687,400.

    13F-HR 0001172661-26-005349 filed by ORBIMED ADVISORS LLC
    Accepted , ingested

  2. period ended2026-06-30
    13F 220,000 shares
    Change vs previous 13F +220,000 shares

    0.04% of the 13F portfolio, value $2,160,400.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -157,300 shares

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2025-12-31
    13F 157,300 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $1,909,622.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).